Galectin‐3: a novel mediator of heart failure development and progression

RA de Boer, AA Voors, P Muntendam… - European journal of …, 2009 - Wiley Online Library
Galectins are a family of soluble β‐galactoside‐binding lectins that play many important
regulatory roles in inflammation, immunity, and cancer. Recently, a role for galectin‐3 in the …

Treating oxidative stress in heart failure: past, present and future

A van der Pol, WH van Gilst, AA Voors… - European Journal of …, 2019 - Wiley Online Library
Advances in cardiovascular research have identified oxidative stress as an important
pathophysiological pathway in the development and progression of heart failure. Oxidative …

[HTML][HTML] Telomere biology in healthy aging and disease

H Oeseburg, RA de Boer, WH Van Gilst… - … -European Journal of …, 2010 - Springer
Aging is a biological process that affects most cells, organisms and species. Telomeres have
been postulated as a universal biological clock that shortens in parallel with aging in cells …

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

CKDGen Consortium, KidneyGen Consortium… - Nature, 2011 - nature.com
Blood pressure is a heritable trait influenced by several biological pathways and responsive
to environmental stimuli. Over one billion people worldwide have hypertension (≥ 140 mm …

Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population

HL Hillege, V Fidler, GFH Diercks, WH van Gilst… - Circulation, 2002 - Am Heart Assoc
Background—For the general population, the clinical relevance of an increased urinary
albumin excretion rate is still debated. Therefore, we examined the relationship between …

Genome-wide association study identifies eight loci associated with blood pressure

C Newton-Cheh, T Johnson, V Gateva, MD Tobin… - Nature …, 2009 - nature.com
Elevated blood pressure is a common, heritable cause of cardiovascular disease worldwide.
To date, identification of common genetic variants influencing blood pressure has proven …

[HTML][HTML] Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an …

K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy… - The Lancet, 2021 - thelancet.com
Background The effects of pharmacological blood pressure lowering at normal or high-
normal blood pressure ranges in people with or without pre-existing cardiovascular disease …

The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe: Part 1: patient characteristics and diagnosis

JGF Cleland, K Swedberg, F Follath… - European heart …, 2003 - academic.oup.com
Abstract Background The European Society of Cardiology (ESC) has published guidelines
for the investigation of patients with suspected heart failure and, if the diagnosis is proven …

Identification of seven loci affecting mean telomere length and their association with disease

V Codd, CP Nelson, E Albrecht, M Mangino, J Deelen… - Nature …, 2013 - nature.com
Interindividual variation in mean leukocyte telomere length (LTL) is associated with cancer
and several age-associated diseases. We report here a genome-wide meta-analysis of …

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular …

HL Hillege, WMT Janssen, AAA Bak… - Journal of internal …, 2001 - Wiley Online Library
Hillege HL, Janssen WMT, Bak AAA, Diercks GFH, Grobbee DE, Crijns HJGM, van Gilst WH,
de Zeeuw D, de Jong PE for the PREVEND Study group (University of Groningen and …